These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25591674)

  • 1. Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
    Neurol India; 2014; 62(6):625-30. PubMed ID: 25591674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for age at onset of dementia due to Alzheimer's disease in a sample of patients with low mean schooling from São Paulo, Brazil.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1033-9. PubMed ID: 24596166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study.
    Rusanen M; Kivipelto M; Levälahti E; Laatikainen T; Tuomilehto J; Soininen H; Ngandu T
    J Alzheimers Dis; 2014; 42(1):183-91. PubMed ID: 24825565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia.
    Luck T; Riedel-Heller SG; Luppa M; Wiese B; Köhler M; Jessen F; Bickel H; Weyerer S; Pentzek M; König HH; Prokein J; Ernst A; Wagner M; Mösch E; Werle J; Fuchs A; Brettschneider C; Scherer M; Maier W
    Psychol Med; 2014 Apr; 44(6):1319-29. PubMed ID: 23883793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.
    de Oliveira FF; Pereira FV; Pivi GAK; Smith MC; Bertolucci PHF
    Int J Neurosci; 2018 May; 128(5):472-476. PubMed ID: 29064737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Wajman JR; Bertolucci PH; Chen ES; Smith MC
    Clin Neurol Neurosurg; 2015 Aug; 135():27-33. PubMed ID: 26010393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
    Ferrari C; Xu WL; Wang HX; Winblad B; Sorbi S; Qiu C; Fratiglioni L
    Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic characteristics, clinical factors, and genetic polymorphisms associated with Alzheimer's disease.
    Bicalho MA; Pimenta FA; Bastos-Rodrigues L; de Oliveira Hansen É; Neves SC; Melo M; Rosa DV; Pedra de Souza R; Marques de Miranda D; Nunes de Moraes E; Romano-Silva MA; De Marco L
    Int J Geriatr Psychiatry; 2013 Jun; 28(6):640-6. PubMed ID: 22899317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.
    de Oliveira FF; de Almeida SS; Chen ES; Smith MC; Naffah-Mazzacoratti MDG; Bertolucci PHF
    J Alzheimers Dis; 2018; 65(4):1283-1299. PubMed ID: 30149448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Heser K; Tebarth F; Wiese B; Eisele M; Bickel H; Köhler M; Mösch E; Weyerer S; Werle J; König HH; Leicht H; Pentzek M; Fuchs A; Riedel-Heller SG; Luppa M; Prokein J; Scherer M; Maier W; Wagner M;
    Psychol Med; 2013 Aug; 43(8):1597-610. PubMed ID: 23137390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from São Paulo, Brazil.
    de Oliveira FF; Pivi GA; Chen ES; Smith MC; Bertolucci PH
    J Neurol Sci; 2015 Dec; 359(1-2):127-32. PubMed ID: 26671101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
    Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study.
    Vermeiren AP; Bosma H; Visser PJ; Zeegers MP; Graff C; Ewers M; Frisoni GB; Frölich L; Hampel H; Jones RW; Kehoe PG; Lenoir H; Minthon L; Nobili FM; Olde Rikkert M; Rigaud AS; Scheltens P; Soininen H; Spiru L; Tsolaki M; Wahlund LO; Vellas B; Wilcock G; Elias-Sonnenschein LS; Verhey FR
    J Alzheimers Dis; 2013; 35(2):241-6. PubMed ID: 23380990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.